Download presentation
Presentation is loading. Please wait.
Published byĐoàn Kha Modified over 5 years ago
1
P3.02a-036 Phase 1 Study of Ceritinib 450 mg or 600 mg Taken with a Low-Fat Meal versus 750 mg in Fasted State in ALK+ Metastatic NSCLC Rafal Dziadziuszko, Dong-Wan Kim, Alessandra Bearz, Scott Laurie, Mark Mckeage, Keunchil Park, Sang-We Kim, Vanessa Q. Passos, Karen Osborne, Yvonne Y. Lau, Jessie Gu, Byoung Chul Cho Journal of Thoracic Oncology Volume 12, Issue 1, (January 2017) DOI: /j.jtho Copyright © Terms and Conditions
2
Journal of Thoracic Oncology 2017 12, DOI: (10. 1016/j. jtho. 2016. 11
Copyright © Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.